| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
| mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.05 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.05 |
| mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |